Lee Financial CO Alkermes Plc. Transaction History

Lee Financial CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$27.94 - $44.61 $6,705 - $10,706	-240 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$38.6 - $46.12 $1,930 - $2,306	-50 Reduced 17.24%	240 $10,000
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $4,745 - $6,009	117 Added 67.63%	290 $12,000
Q1 2018 May 09, 2018	SELL	$53.61 - $67.26 $375 - $470	-7 Reduced 3.89%	173 $10,000
Q4 2017 Feb 09, 2018	BUY	$47.69 - $55.39 $8,584 - $9,970	180	180 $10,000

375

166M

231K

158K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.42B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.